AFRJMS African Research Journal of Medical Sciences 3006-7421 Bioscience Press afrjms-1-2-005 10.62587/AFRJMS.1.2.2024.58-61 Research Paper Computation analysis of histone deacetylases with curcumin FerrariIvan Vito 1 * 1Institute of Clinical Physiology, National Research Council, Via Aurelia Sud, 54100 Massa, Italy. E-mail: ivanvitoferrari@gmail.com *Corresponding author: Ivan Vito Ferrari, Institute of Clinical Physiology, National Research Council, Via Aurelia Sud, 54100 Massa, Italy. E-mail: ivanvitoferrari@gmail.com 07 2024 1 2 58 61 Abstract

The assessment of histone deacetylases in conjunction with curcumin, conducted through the Mcule Database employing the Autodock Vina algorithm, involves an examination of molecular interactions. This analysis includes the calculation of binding energies, revealing the strength and stability of the interactions between curcumin and various histone deacetylase targets. The comparison encompasses diverse aspects such as binding energies, specific binding sites, interactions across different targets, structural details, and potential implications for biological activity. The results imply that curcumin shows heightened affinity for histone deacetylase 4 in comparison to other investigated histone deacetylases.

 Keywords HDACs Curcumin Molecular docking References AggarwalB.B.KumarA.BhartiA.C. (2003). Anticancer potential of curcumin: preclinical and clinical studies. Anticancer research, 23(1/A): 363–398. Barneda-ZahoneroB.ParraM. (2012). Histone deacetylases and cancer. Molecular oncology, 6(6): 579–589. CressW.D.SetoE. (2000). Histone deacetylases, transcriptional control, and cancer. Journal of cellular physiology, 184(1): 1–16. DokmanovicM.ClarkeC.MarksP.A. (2007). Histone deacetylase inhibitors: overview and perspectives. Molecular cancer research, 5(10): 981–989. GlozakM.A.SetoE. (2007). Histone deacetylases and cancer. Oncogene, 26(37): 5420–5432. GrayS.G.EkströmT.J. (2001). The human histone deacetylase family. Experimental cell research, 262(2): 75–83. GrozingerC.M.SchreiberS.L. (2000). Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proceedings of the national academy of sciences, 97(14): 7835–7840. MarksP.A.MillerT.RichonV.M. (2003). Histone deacetylases. Current opinion in pharmacology, 3(4): 344–351. MarksP.A.RichonV.M.MillerT.KellyW.K. (2004). Histone deacetylase inhibitors. Advances in cancer research, 91: 137–168. MengX.Y.ZhangH.X.MezeiM.CuiM. (2011). Molecular docking: a powerful approach for structurebased drug discovery. Current computer-aided drug design, 7(2): 146–157. OdharH.A.RayshanA.M.AhjelS.W.HashimA.A.AlbeerA.A.M.A. (2019). Molecular docking enabled updated screening of the matrix protein VP40 from Ebola virus with millions of compounds in the MCULE database for potential inhibitors. Bioinformation, 15(9): 627. VallianouN.G.EvangelopoulosA.SchizasN.KazazisC. (2015). Potential anticancer properties and mechanisms of action of curcumin. Anticancer research, 35(2): 645–651. VegaR.B.MatsudaK.OhJ.BarbosaA.C.YangX.MeadowsE.OlsonE.N. (2004). Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell, 119(4): 555–566. WangA.H.KruhlakM.J.WuJ.BertosN.R.VezmarM.PosnerB.I.YangX.J. (2000). Regulation of histone deacetylase 4 by binding of 14-3-3 proteins. Molecular and cellular biology, 20(18): 6904–6912.